Chemical Compound

(8S,10S)-6,8,11-Trihydroxy-10-(((2R,4S,5S,6S)-5-hydroxy-4-((S)-2-methoxymorpholino)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione

CAS Registry Number 108852-90-0
返回搜索 申请报价
(8S,10S)-6,8,11-Trihydroxy-10-(((2R,4S,5S,6S)-5-hydroxy-4-((S)-2-methoxymorpholino)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione 结构式
Primary record

(8S,10S)-6,8,11-Trihydroxy-10-(((2R,4S,5S,6S)-5-hydroxy-4-((S)-2-methoxymorpholino)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione

库存
9,392 克
纯度
99.4 %
CAS
108852-90-0

化合物标识与属性

CAS
108852-90-0
PubChem CID
65907
SMILES
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N6CCO[C@@H](C6)OC)O
Canonical SMILES
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N2CCO[C@H](OC)C2)[C@H](O)[C@H](C)O1

名称与同义词

  • Nemorubicin
  • nemorubicina
  • nemorubicine
  • nemorubicinum
  • Nemorubicinol
  • Nemorbicin
  • Nemorubicin [INN]
  • methoxymorpholinoDX
  • 108852-90-0
  • Methoxymorpholino-doxorubicin
  • Nemorubicin (GMP)
  • MMDX
  • Methoxymorpholinyl doxorubicin
  • MMDOX
  • RefChem:165053
  • methoxymorpholinyl-doxorubicin
  • pnu 152243
  • DTXSID6057619
  • FCE-23762
  • CHEBI:42053
  • D0K2CR
  • methoxy-morpholinyl-doxorubicin
  • Methoxymorpholinyldoxorubicin
  • UNII-7618O47BQM
  • 7618O47BQM
  • Fce 23762
  • SCHEMBL24646
  • NEMORUBICIN [WHO-DD]
  • CTMCWCONSULRHO-UHQPFXKFSA-N
  • C32H37NO13
  • orb1302833
  • PNU152243A
  • CHEMBL1232279
  • SCHEMBL29388170
  • MFCD00871079
  • BADC-00088
  • DTXCID301508600
  • GLXC-05427
  • PNU-152243
  • AC1L2482
  • AMY10326
  • CID65907
  • (2S)-2-Methoxymorpholinodoxorubicin
  • BDBM50633982
  • CID:65907
  • FCE-23672
  • HY-15794G
  • ZINC49757291
  • AKOS030526068
  • C32-H37-N-O13
  • ACN-037651
  • CS-2020
  • PNU-156685
  • PNU-156686
  • PNU-159682
  • AC-37942
  • BP-29358
  • BP-43667
  • HY-15794
  • MS-30933
  • SID:53789682
  • Methoxymorpholinyl doxorubicin hydrochloride
  • SID:405116835
  • J488.795F
  • 2-amino-pyrido[3,2-d]pyrimidin-4(1h)-one
  • B1136
  • CS-0899274
  • NS00120826
  • 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN
  • 3'-deamino-3'-(2-methoxymorpholin-4-yl)doxorubicin
  • A14363
  • F84993
  • 33952-EP2270008A1
  • 33952-EP2275420A1
  • 33952-EP2292617A1
  • 33952-EP2295055A2
  • 33952-EP2295416A2
  • 33952-EP2295426A1
  • 33952-EP2295427A1
  • 33952-EP2298748A2
  • 33952-EP2298764A1
  • 33952-EP2298765A1
  • 33952-EP2305642A2
  • 33952-EP2308855A1
  • 33952-EP2311453A1
  • 3'-deamino-3'-(2(S)-methoxy-4-morpholinyl)doxorubicin
  • A855698
  • C066998
  • BRD-K51911221-001-01-2
  • Q27120450
  • (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-[(2S)-2-methoxymorpholin-4-yl]-alpha-L-lyxo-hexopyranoside
  • (1S,3S)-3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 2,3,6-trideoxy-3-((S)-2-methoxymorpholino)-alpha-L-lyxo-hexopyranoside
  • C000609287
  • (7S,9S)-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-7-[(2R,4S,5S,6S)-5-hydroxy-4-[(2S)-2-methoxymorpholin-4-yl]-6-methyloxan-2-yl]oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
  • Methoxymorpholinyldoxorubicin;PNU-152243;PNU 152243;PNU152243;PNU-152243A
  • (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-((2S)-2-methoxymorpholin-4-yl)-alpha-L-lyxo-hexopyranoside
  • (1S,3S)-3-GLYCOLOYL-1,2,3,4,6,11-HEXAHYDRO-3,5,12-TRIHYDROXY-10-METHOXY-6,11-DIOXO-1-NAPHTHACENYL 2,3,6-TRIDEOXY-3-((S)-2-METHOXYMORPHOLINO)-.ALPHA.-L-LYXO-HEXOPYRANOSIDE
  • (7S,9S)-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-7-[(2R,4S,5S,6S)-5-hydroxy-4-[(2S)-2-methoxymorpholin-4-yl]-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
  • (8S)-10alpha-[[3-[(2S)-2alpha-Methoxymorpholino]-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8alpha,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
  • (8S,10S)-6,8,11-Trihydroxy-10-(((2R,4S,5S,6S)-5-hydroxy-4-((S)-2-methoxymorpholino)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
  • (8S,10S)-6,8,11-TRIHYDROXY-10-{[(2R,4S,5S,6S)-5-HYDROXY-4-[(2S)-2-METHOXYMORPHOLIN-4-YL]-6-METHYLOXAN-2-YL]OXY}-8-(2-HYDROXYACETYL)-1-METHOXY-5,7,8,9,10,12-HEXAHYDROTETRACENE-5,12-DIONE
  • 10alpha-[[3-[(2S)-2-Methoxy-4-morpholinyl]-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8beta-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
  • 5,12-NAPHTHACENEDIONE, 7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(2-HYDROXYACETYL)-1-METHOXY-10-((2,3,6-TRIDEOXY-3-((2S)-2-METHOXY-4-MORPHOLINYL)-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-, (8S,10S)-
  • 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(2S)-2-methoxy-4-morpholinyl]-a-Llyxo- hexopyranosyl]oxy]-, (8S,10S)-
  • 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-((2,3,6-trideoxy-3-(2-methoxy-4-morpholinyl)-alpha-L-lyxo-hexopyranosyl)oxy)-, (8S-cis)-
  • 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(2S)-2-methoxy-4-morpholinyl]-.alpha.-L-lyxo-hexopyranosyl]oxy]-, (8S,10S)-
  • DMM